Evidence map›Paper›PMID 36456739›Full record

ArticleNature immunology2022

Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis.

Mangalakumari Jeyanathan, Maryam Vaseghi-Shanjani, Sam Afkhami, Jensine A Grondin, Alisha Kang, Michael R D'Agostino, Yushi Yao, Shreya Jain, Anna Zganiacz, Zachary Kroezen and 6 more

Erratum issued Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Nature immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07527247 (Using AS01 Adjuvant to Improve Immune Response in Older Adults Through Trained Immunity), which is not on this map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07527247 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Using AS01 Adjuvant to Improve Immune Response in Older Adults Through Trained Immunity

TypeinterventionalSponsorSingapore General HospitalRan2025 to 2029Enrolled40ConditionsImmune System Responses and Trained Immunity After AS01 Administration, Healthy AdultArmsAS01 adjuvant (0.5 mL intramuscular), YF17D (Stamaril, Sanofi-Pasteur), Placebo (NaCl 09%, 0.5mL)
3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 151 citations in OpenAlex.

  1. Route of BCG administration determines success.Human vaccines & immunotherapeutics · 2026
    Review
  2. Review
  3. Review
  4. MaternalBiomedicines · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. BCG HSP70 Reprograms Macrophages via Central Trained Immunity to Suppress Prostate Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Mangalakumari JeyanathanMcMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Maryam Vaseghi-ShanjaniMcMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Sam AfkhamiMcMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Jensine A GrondinFarncombe Family Digestive Health Research Institute and Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Alisha KangMcMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Michael R D'AgostinoMcMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Yushi YaoMcMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Shreya JainMcMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Anna ZganiaczMcMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Zachary KroezenDepartment of Chemistry and Chemical Biology, McMaster University, Hamilton, Ontario, Canada.
Meera ShanmuganathanDepartment of Chemistry and Chemical Biology, McMaster University, Hamilton, Ontario, Canada.
Ramandeep SinghMcMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Anna Dvorkin-GhevaMcMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Philip Britz-McKibbinDepartment of Chemistry and Chemical Biology, McMaster University, Hamilton, Ontario, Canada.
Waliul I KhanFarncombe Family Digestive Health Research Institute and Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Zhou XingMcMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research and Department of Medicine, McMaster University, Hamilton, Ontario, Canada. xingz@mcmaster.ca.ORCID http://orcid.org/0000-0001-7856-0663
McMaster University · CAPopulation Health Research Institute · CAMcMaster University Medical Centre · CAZhejiang University · CN

Funding

CIHR FDN-154316
6 · The paper itself

Abstract

Aside from centrally induced trained immunity in the bone marrow (BM) and peripheral blood by parenteral vaccination or infection, evidence indicates that mucosal-resident innate immune memory can develop via a local inflammatory pathway following mucosal exposure. However, whether mucosal-resident innate memory results from integrating distally generated immunological signals following parenteral vaccination/infection is unclear. Here we show that subcutaneous Bacillus Calmette-Guérin (BCG) vaccination can induce memory alveolar macrophages (AMs) and trained immunity in the lung. Although parenteral BCG vaccination trains BM progenitors and circulating monocytes, induction of memory AMs is independent of circulating monocytes. Rather, parenteral BCG vaccination, via mycobacterial dissemination, causes a time-dependent alteration in the intestinal microbiome, barrier function and microbial metabolites, and subsequent changes in circulating and lung metabolites, leading to the induction of memory macrophages and trained immunity in the lung. These data identify an intestinal microbiota-mediated pathway for innate immune memory development at distal mucosal tissues and have implications for the development of next-generation vaccine strategies against respiratory pathogens.

Indexed as

BCG VaccineMacrophages, AlveolarImmunity, InnateLungTrained ImmunityVaccinationBCG Vaccine

Identifiers

PMID36456739
PMCPMC9747617
OpenAlexW4310588974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.